about
Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary reportRetinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patientsAutoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's diseaseDecreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency.Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates.Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome.MRI correlates of disability progression in patients with CIS over 48 months.Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease.Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study.Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRIQuantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosisA semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation proceduresClinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area.Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA).Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study.Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study.Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis.Neck Vessel Cross-Sectional Area Measured with MRI: Scan-Rescan Reproducibility for Longitudinal Evaluations.Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome.Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis.Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study.Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis.Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
P50
Q21245254-8EEDAAD0-7929-455E-BBC9-E18C98784A82Q28303640-107ED4E5-C69E-4D22-8695-44C46DE65A19Q31047731-BEFB1F1C-72C2-40E2-AD82-ADC657C9B9A0Q33699736-F72E4DC1-60FA-4BB4-B5B9-140BE62B9D88Q34051741-7305ED56-795E-43FA-B588-02DB3373C4B0Q34343868-BFBDB33C-926F-432C-98A6-2193AB005F45Q34397786-E2C0E2C7-71D3-481B-AE4B-120E08663198Q34431806-1C03F17C-4060-4A1D-AA78-6F58B7001F51Q34493638-94FF4E7E-D718-4644-A024-2EBFB2CC0869Q34548374-BADD286F-BA0F-4709-8802-A71FE3F25199Q34978091-8BE14BF6-B75F-439E-AA4E-07890F9AB590Q35041978-438BA94C-6DAE-4556-8263-73EE20F36304Q35119866-65EC988B-26D6-44AA-8E9F-AE6226D50F05Q35586845-65342EBC-1CC9-442A-BC0F-42C70CA5727AQ35893074-FC41891B-E057-45A2-8AD3-DFE08DDB373DQ35997017-E888B550-641A-46BA-B0E1-AB3FE4F00D89Q37717802-FAC66A7E-E2BF-41D2-86CF-6667FDAB0A07Q38927233-97D57091-3BB1-4D28-B93B-6D7633EC33E3Q39872443-EEE8AD39-46D6-4823-ACD4-831BA7F01B68Q43035274-71F0248A-F879-400C-B1EE-038F7F24C4FBQ44320195-D8C23072-CB95-4E1B-A01A-ED5C56028337Q44486220-F2A7CE7C-AC5E-41E8-BDE5-7E4A96518C32Q44642567-C0A7C90E-90B3-4D30-BFB9-1CE33FCE3B3AQ45305422-EFEBE1F6-956B-4EA2-B894-DA486EC77697Q45998751-4AFA8E35-A0C4-47E1-8380-27E11DA574C0Q46054853-32276B81-21CA-47BC-981C-2DA32E6EAFECQ46148199-93864A30-8279-4697-A837-EA6E5A064A47Q46466612-AE47C580-DFB9-44AE-93EE-DEEAAA45A124Q46561361-BD244E5C-152E-4AD1-AD64-C4F67A3A9FDDQ47690707-A54AD314-3EA8-41D4-A299-A204770F043DQ47820950-8748467E-D21D-4DAC-9E8F-5BE1DE42D6CAQ47908989-1F3C4ABD-3A68-4880-962F-315A2B68E339Q48108313-82B02805-DA7D-46D1-A71A-AA5F2F92405FQ48133138-D6BE714F-40DC-4D3E-950A-1408424BDA48Q48145918-CD4EE046-3221-4756-935D-4F705B85A29FQ48154852-0B4C819F-F1F8-46C1-9871-60E3A88E022FQ48174439-CF9897A4-B6C6-47E8-B056-F3006C1DCD68Q48197789-02EDD5CB-641D-49A3-8035-5616BA893237Q48204718-8E252233-8A7E-41A6-A4DE-109C0B279E0AQ48215414-1460AD76-EE56-4F19-9E03-FA5097BB9512
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Niels Bergsland
@ast
Niels Bergsland
@en
Niels Bergsland
@es
Niels Bergsland
@nl
Niels Bergsland
@sl
type
label
Niels Bergsland
@ast
Niels Bergsland
@en
Niels Bergsland
@es
Niels Bergsland
@nl
Niels Bergsland
@sl
prefLabel
Niels Bergsland
@ast
Niels Bergsland
@en
Niels Bergsland
@es
Niels Bergsland
@nl
Niels Bergsland
@sl
P106
P21
P31
P496
0000-0002-7792-0433